Xiaoming Ding

Dr. Xiaoming Ding


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2010 in Cell Research
Verified
Journal Article
Open access
PDF file
WZWei Zhao
Wei Zhao
YZYi Zhong
Yi Zhong
HYHua Yuan
Hua Yuan
JWJin Wang
Jin Wang
HZHuajun Zheng
Huajun Zheng
GZGuoping Zhao
Guoping Zhao
Amycolatopsis mediterranei is used for industry-scale production of rifamycin, which plays a vital role in antimycobacterial therapy. As the first sequenced genome of the genus Amycolatopsis, the chromosome of strain U32 comprising 10 236 715 base pairs, is one of the largest prokaryotic genomes ever sequenced so far. Unlike the linear topology found in streptomycetes, this chromosome is circular, particularly similar to that of Saccharopolyspora erythraea and Nocardia farcinica, representing their close relationship in phylogeny and taxonomy. Although the predicted 9 228 protein-coding genes in the A. mediterranei genome shared the greatest number of orthologs with those of S. erythraea, it was unexpectedly followed by Streptomyces coelicolor rather than N. farcinica, indicating the distinct metabolic characteristics evolved via adaptation to diverse ecological niches. Besides a core region analogous to that common in streptomycetes, a novel 'quasi-core' with typical core characteristics is defined within the non-core region, where 21 out of the total 26 gene clusters for secondary metabolite production are located. The rifamycin biosynthesis gene cluster located in the core encodes a cytochrome P450 enzyme essential for the conversion of rifamycin SV to B, revealed by comparing to the highly homologous cluster of the rifamycin B-producing strain S699 and further confirmed by genetic complementation. The genomic information of A. mediterranei demonstrates a metabolic network orchestrated not only for extensive utilization of various carbon sources and inorganic nitrogen compounds but also for effective funneling of metabolic intermediates into the secondary antibiotic synthesis process under the control of a seemingly complex regulatory mechanism.

3 November 2011 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LZLin Zhang
Lin Zhang
GZGuoping Zhao
Guoping Zhao
XDXiaoming Ding
Xiaoming Ding
We describe a site-specific recombination-based tandem assembly (SSRTA) method for reconstruction of biological parts in synthetic biology. The system was catalyzed by Streptomyces phage φBT1 integrase, which belongs to the large serine recombinase subfamily. This one-step approach was efficient and accurate, and able to join multiple DNA molecules in vitro in a defined order. Thus, it could have applications in constructing metabolic pathways and genetic networks.

1 October 2008 in Journal of Bacteriology
Verified
Journal Article
Closed access
PDF file
LZLin Zhang
Lin Zhang
XOXijun Ou
Xijun Ou
GZGuoping Zhao
Guoping Zhao
XDXiaoming Ding
Xiaoming Ding
The Streptomyces phage φBT1 encodes a site-specific integrase of the large serine recombinase subfamily. In this report, the enzymatic activity of the φBT1 integrase was characterized in vitro. We showed that this integrase has efficient integration activity with substrate DNAs containing attB and attP sites, independent of DNA supercoiling or cofactors. Both intra- and intermolecular recombinations proceed with rapid kinetics. The recombination is highly specific, and no reactions are observed between pairs of sites including attB and attL, attB and attR, attP and attL, or attP and attR or between two identical att sequences; however, a low but significant frequency of excision recombination between attL and attR is observed in the presence of the φBT1 integrase alone. In addition, for efficient integration, the minimal sizes of attB and attP are 36 bp and 48 bp, respectively. This site-specific recombination system is efficient and simple to use; thus, it could have applications for the manipulation of DNA in vitro.

18 May 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
XBXiaoying Bian
Xiaoying Bian
BTBiao Tang
Biao Tang
YYYucong Yu
Yucong Yu
QTQiang Tu
Qiang Tu
FGFrank Gross
Frank Gross
YZYouming Zhang
Youming Zhang

1 April 2009 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
XOXijun Ou
Xijun Ou
BZBo Zhang
Bo Zhang
LZLin Zhang
Lin Zhang
GZGuoping Zhao
Guoping Zhao
XDXiaoming Ding
Xiaoming Ding
Streptomycesnot only exhibits complex morphological differentiation but also produces a plethora of secondary metabolites, particularly antibiotics. To improve our general understanding of the complex network of undecylprodigiosin (Red) biosynthesis regulation, we used an in vivo transposition system to identify novel regulators that influence Red production inStreptomyces coelicolorM145. Using this screening system, we obtained 25 Red-deficient mutants. Twenty-four of these mutants had a transposon inserted in the previously described Red biosynthetic gene cluster and produced different amounts of another secondary metabolite, actinorhodin (Act). One mutant was shown to have an insertion in a different region of the chromosome upstream of the previously uncharacterized generrdA(regulator ofredD, sco1104), which encodes a putative TetR family transcription factor. Compared with wild-type strain M145, therrdAnull mutant exhibited increased Red production and decreased Act production. A high level ofrrdAexpression resulted in a severe reduction in Red production and Act overproduction. Reverse transcription-PCR analysis showed that RrdA negatively regulated Red production by controllingredDmRNA abundance, while no change was observed at the transcript level of the Act-specific activator gene,actII-orf4. The effects on Act biosynthesis might arise from competition for precursors that are common to both pathways.

16 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HWHu Wang
Hu Wang
GZGuoping Zhao
Guoping Zhao
XDXiaoming Ding
Xiaoming Ding
Growth ofStreptomycesin submerged culture is characterized by the formation of complex mycelial particles, known as pellets or clumps, which strongly influence antibiotic production. Also, many bioactive molecules produced byStreptomyceshave great potential to modulate soil bacteria morphological development. However, there has been no effort directed at engineering mycelial morphology using these small molecules. Here, thiostrepton was identified, using a combination of qRT-PCR, semi-preparative HPLC, and MALDI-TOF MS, as a pellet-inducing compound produced byS. laurentiiATCC31255. At sub-inhibitory concentration, thiostrepton stimulatedStreptomyces coelicolorM145 pellet formation and antibiotics production were altered, with 3-fold and 2-fold decreases in actinorhodin and undecylprodigiosin yields, respectively. It was also shown that mycelial morphology can be influenced by other antibiotic class at sub-inhibitory concentrations. For instance, in the presence of spectinomycin,S. coelicolorM145, which under typical growth conditions forms large diameter pellets with many protruding hyphae, instead formed small diameter pellets with barely visible hyphae at the edge. Importantly, this morphology produced a 4-fold increase in undecylprodigiosin production and 3-fold decrease in actinorhodin production. These results indicated that these small molecules, previously identified as antimicrobials, also have great potential for influencing mycelial morphology.